Stay Curious

SIGN UP FOR OUR WEEKLY NEWSLETTER AND UNLOCK ONE MORE ARTICLE FOR FREE.

Sign Up

VIEW OUR Privacy Policy


Discover Magazine Logo

WANT MORE? KEEP READING FOR AS LOW AS $1.99!

Subscribe

ALREADY A SUBSCRIBER?

FIND MY SUBSCRIPTION
Advertisement

Four Hemophiliac Patients Successfully Treated with Gene Therapy

Discover the potential of gene therapy treatment that may revolutionize hemophilia care by curing patients with defective blood clotting factors.

Newsletter

Sign up for our email newsletter for the latest science news

Sign Up

Hemophilia

, a disease whose victims can suffer serious internal bleeding and may bleed to death from injuries, has a long and eventful history. Caused by defective blood clotting factors, the disease has been with us since at least the second century

, when a rabbi gave mothers whose first two sons had bled to death from circumcision wounds permission to leave the third sons uncircumcised. It also famously afflicted several members of European royal families

. But a study

published in the New England Journal of Medicine brings us a bit closer to a new kind of historic event: a cure. Following up on years of preclinical trials, including the curing of hemophiliac mice earlier this year

, scientists gave six patients a gene therapy

treatment, injecting them with a specially built virus carrying a functioning version of the gene for the defective clotting factor. The virus inserted the ...

Stay Curious

JoinOur List

Sign up for our weekly science updates

View our Privacy Policy

SubscribeTo The Magazine

Save up to 40% off the cover price when you subscribe to Discover magazine.

Subscribe
Advertisement

0 Free Articles